QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 105
Summary
- Conditions
- Gastric Cancer
- Cervical Cancer
- Colorectal Cancer
- Head and Neck Squamous Cell Carcinoma
- Hepatocellular Carcinoma
- Melanoma
- Merkel Cell Carcinoma
- Microsatellite Instability
- Urothelial Carcinoma
- Mismatch Repair Deficiency
- Non -Small Cell Lung Cancer
- Renal Cell Carcinoma
- Small Cell Lung Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03228667
- Collaborators
- Not Provided
- Investigators
- Study Director: Chad Garner, PhD ImmunityBio, Inc.